Dilated cardiomyopathy in infants and children
ML Griffin,
A Hernandez,
TC Martin,
D Goldring,
RM Bolman,
TL Spray,
and
AW Strauss
Washington University School of Medicine, Edward Mallinckrodt Department of Pediatrics, St. Louis, Missouri.
The outcome of medical treatment of dilated cardiomyopathy in infants and children was reviewed to develop a predictive index for selection of patients likely to benefit from cardiac transplantation. The clinical findings, laboratory investigations, treatment and outcome of 20 patients (Group 1) less than 2 years of age at presentation and 12 patients (Group 2) greater than 2 years of age at onset were compared. Of 20 Group 1 patients, 5 (25%) died. Available autopsies (four patients) showed endocardial fibroelastosis. Of 15 survivors, 10 showed improvement in cardiac status and 5 remained unchanged. Ninety-three percent of survivors had dilated cardiomyopathy consistent with endocardial fibroelastosis by angiocardiography. All 12 Group 2 patients died. In addition to age at presentation and poor outcome, Group 2 differed from Group 1 in having a higher incidence of other family members with cardiomyopathy, more significant rhythm disturbances at presentation and a more rapid course to death. Risk factors of poor outcome in both groups included persistent cardiomegaly and the development of significant arrhythmias by Holter electrocardiographic monitoring. Cardiac transplantation is recommended for children with dilated cardiomyopathy presenting after age 2 years who survive 1 month. Those patients less than 2 years old at presentation whose condition has not improved after 1 year and who have persistent cardiomegaly or complex ventricular arrhythmias may also benefit from transplantation.
This article has been cited by other articles:

|
 |

|
 |
 
D. T. Hsu and G. D. Pearson
Heart Failure in Children: Part II: Diagnosis, Treatment, and Future Directions
Circ Heart Fail,
September 1, 2009;
2(5):
490 - 498.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. E. Andrews, M. J. Fenton, D. A. Ridout, M. Burch, and on Behalf of the British Congenital Cardiac Associ
New-Onset Heart Failure Due to Heart Muscle Disease in Childhood: A Prospective Study in the United Kingdom and Ireland
Circulation,
January 1, 2008;
117(1):
79 - 84.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. E. Canter, R. E. Shaddy, D. Bernstein, D. T. Hsu, M. R.K. Chrisant, J. K. Kirklin, K. R. Kanter, R. S.D. Higgins, E. D. Blume, D. N. Rosenthal, et al.
Indications for Heart Transplantation in Pediatric Heart Disease: A Scientific Statement From the American Heart Association Council on Cardiovascular Disease in the Young; the Councils on Clinical Cardiology, Cardiovascular Nursing, and Cardiovascular Surgery and Anesthesia; and the Quality of Care and Outcomes Research Interdisciplinary Working Group
Circulation,
February 6, 2007;
115(5):
658 - 676.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. A. Towbin, A. M. Lowe, S. D. Colan, L. A. Sleeper, E. J. Orav, S. Clunie, J. Messere, G. F. Cox, P. R. Lurie, D. Hsu, et al.
Incidence, causes, and outcomes of dilated cardiomyopathy in children.
JAMA,
October 18, 2006;
296(15):
1867 - 1876.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. L. Burkett and R. E. Hershberger
Clinical and genetic issues in familial dilated cardiomyopathy
J. Am. Coll. Cardiol.,
April 5, 2005;
45(7):
969 - 981.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M Burch
Immune suppressive treatment in paediatric myocarditis: still awaiting the evidence
Heart,
October 1, 2004;
90(10):
1103 - 1104.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M G. Gagliardi, M Bevilacqua, C Bassano, B Leonardi, R Boldrini, F D. Camassei, A Fierabracci, A G Ugazio, and G F Bottazzo
Long term follow up of children with myocarditis treated by immunosuppression and of children with dilated cardiomyopathy
Heart,
October 1, 2004;
90(10):
1167 - 1171.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. E. Tsirka, K. Trinkaus, S.-C. Chen, S. E. Lipshultz, J. A. Towbin, S. D. Colan, V. Exil, A. W. Strauss, and C. E. Canter
Improved outcomes of pediatric dilated cardiomyopathy with utilization of heart transplantation
J. Am. Coll. Cardiol.,
July 21, 2004;
44(2):
391 - 397.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Index of Suspicion
Pediatr. Rev.,
March 1, 2004;
25(3):
101 - 108.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. E. Lipshultz, L. A. Sleeper, J. A. Towbin, A. M. Lowe, E. J. Orav, G. F. Cox, P. R. Lurie, K. L. McCoy, M. A. McDonald, J. E. Messere, et al.
The Incidence of Pediatric Cardiomyopathy in Two Regions of the United States
N. Engl. J. Med.,
April 24, 2003;
348(17):
1647 - 1655.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Azeka, J. A. Franchini Ramires, C. Valler, and E. Alcides Bocchi
Delisting of infants and children from the heart transplantation waiting list after carvedilol treatment
J. Am. Coll. Cardiol.,
December 4, 2002;
40(11):
2034 - 2038.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P Acar, P Merlet, L Iserin, D Bonnet, D Sidi, A Syrota, and J Kachaner
Impaired cardiac adrenergic innervation assessed by MIBG imaging as a predictor of treatment response in childhood dilated cardiomyopathy
Heart,
June 1, 2001;
85(6):
692 - 696.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
A. Gavazzi, A. Repetto, L. Scelsi, C. Inserra, M.L. Laudisa, C. Campana, C. Specchia, B. Dal Bello, M. Diegoli, L. Tavazzi, et al.
Evidence-based diagnosis of familial non-X-linked dilated cardiomyopathy. Prevalence, inheritance and characteristics
Eur. Heart J.,
January 1, 2001;
22(1):
73 - 81.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
L. A. Vricella, S. R. Gundry, R. L. Larsen, and L. L. Bailey
Successful myocardial volume reduction in a 9-month-old infant
Ann. Thorac. Surg.,
April 1, 2000;
69(4):
1253 - 1255.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. D. Cheitlin, J. S. Alpert, W. F. Armstrong, G. P. Aurigemma, G. A. Beller, F. Z. Bierman, T. W. Davidson, J. L. Davis, P. S. Douglas, L. D. Gillam, et al.
ACC/AHA Guidelines for the Clinical Application of Echocardiography : A Report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Committee on Clinical Application of Echocardiography) Developed in Collaboration With the American Society of Echocardiography
Circulation,
March 18, 1997;
95(6):
1686 - 1744.
[Full Text]
|
 |
|

|
 |

|
 |
 
G. W. Dec and V. Fuster
Idiopathic Dilated Cardiomyopathy
N. Engl. J. Med.,
December 8, 1994;
331(23):
1564 - 1575.
[Full Text]
|
 |
|

|
 |

|
 |
 
K. L. Lane, A. J. Herzberg, K. A. Reimer, W. D. Bradford, and S. A. Schall
Endocardial Fibroelastosis With Coronary Artery Thromboembolus and Myocardial Infarction
Clinical Pediatrics,
October 1, 1991;
30(10):
593 - 598.
[Abstract]
[PDF]
|
 |
|
|